BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36481471)

  • 1. Association of Body Mass Index With Clinicopathological Features of Papillary Thyroid Carcinoma: A Retrospective Study.
    Dong Z; Liu W; Su F; Cheng R
    Endocr Pract; 2023 Feb; 29(2):83-88. PubMed ID: 36481471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Body Mass Index on the Clinicopathologic Features of Papillary Thyroid Carcinoma.
    Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
    Ann Otol Rhinol Laryngol; 2019 Jul; 128(7):625-632. PubMed ID: 30841713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between body mass index and clinicopathological features of papillary thyroid microcarcinoma.
    Liu Z; Maimaiti Y; Yu P; Xiong Y; Zeng W; Li X; Song H; Lu C; Xin Y; Zhou J; Zhang N; Ming J; Liu C; Shi W; Shi L; Li X; Nie X; Huang T
    Int J Clin Exp Med; 2015; 8(9):16472-9. PubMed ID: 26629173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of multifocality in papillary thyroid carcinoma.
    Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of body mass index on the clinicopathological features of 13,995 papillary thyroid tumors.
    Li CL; Dionigi G; Zhao YS; Liang N; Sun H
    J Endocrinol Invest; 2020 Sep; 43(9):1283-1299. PubMed ID: 32166701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential impact of obesity on the aggressiveness of low- to intermediate-risk papillary thyroid carcinoma: results from a MASTER cohort study.
    Kim M; Kang YE; Park YJ; Koo BS; Ku EJ; Choi JY; Lee EK; Kim BH
    Endocrine; 2023 Oct; 82(1):134-142. PubMed ID: 37516686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity and Overweight Are Associated with Minimal Extrathyroidal Extension, Multifocality and Bilaterality of Papillary Thyroid Cancer.
    Kaliszewski K; Diakowska D; Rzeszutko M; Rudnicki J
    J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33801171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices.
    Trésallet C; Seman M; Tissier F; Buffet C; Lupinacci RM; Vuarnesson H; Leenhardt L; Menegaux F
    Surgery; 2014 Nov; 156(5):1145-52. PubMed ID: 24878452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and High Risk Pathological Features of Papillary Thyroid Carcinoma: A Retrospective Analysis of a University Hospital in Pakistan.
    Zaman SU; Awan MS; Sulaiman MA
    Gulf J Oncolog; 2018 May; 1(27):6-10. PubMed ID: 30145545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of obesity with the clinicopathological features of thyroid cancer in a large, operative population: A retrospective case-control study.
    Zhao S; Jia X; Fan X; Zhao L; Pang P; Wang Y; Luo Y; Wang F; Yang G; Wang X; Gu W; Zang L; Pei Y; Du J; Ba J; Dou J; Mu Y; Lyu Z
    Medicine (Baltimore); 2019 Dec; 98(50):e18213. PubMed ID: 31852078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer.
    Kim HJ; Kim NK; Choi JH; Sohn SY; Kim SW; Jin SM; Jang HW; Suh S; Min YK; Chung JH; Kim SW
    Clin Endocrinol (Oxf); 2013 Jan; 78(1):134-40. PubMed ID: 22812676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between obesity and clinicopathological characteristics in patients with papillary thyroid cancer: a study of 1579 cases: a retrospective study.
    Wang H; Wang P; Wu Y; Hou X; Peng Z; Yang W; Guan L; Hu L; Zhi J; Gao M; Zheng X
    PeerJ; 2020; 8():e9675. PubMed ID: 33194342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Body Mass Index and Clinicopathological Factors in Patients with Papillary Thyroid Carcinoma.
    Yan W; Luo X; Gao QJ; Chen BF; Ye H
    Diabetes Metab Syndr Obes; 2024; 17():2013-2019. PubMed ID: 38765470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is body mass index relevant to prognosis of papillary thyroid carcinoma? A clinicopathological cohort study.
    Chung YS; Lee JH; Lee YD
    Surg Today; 2017 Apr; 47(4):506-512. PubMed ID: 27654453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of BMI with Clinicopathological Features of Papillary Thyroid Cancer: A Systematic Review and Meta-Analysis.
    O'Neill RJ; Abd Elwahab S; Kerin MJ; Lowery AJ
    World J Surg; 2021 Sep; 45(9):2805-2815. PubMed ID: 34136926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher body mass index may be a predictor of extrathyroidal extension in patients with papillary thyroid microcarcinoma.
    Choi JS; Kim EK; Moon HJ; Kwak JY
    Endocrine; 2015 Feb; 48(1):264-71. PubMed ID: 24858734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between body mass index and lymph node metastases of patients with papillary thyroid cancer: A retrospective study.
    Wu C; Wang L; Chen W; Zou S; Yang A
    Medicine (Baltimore); 2017 Mar; 96(9):e6202. PubMed ID: 28248875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinicopathological features and prognosis of papillary thyroid carcinoma and microcarcinoma: A population-based propensity score matching analysis.
    Qian B; Hu L; Zhang S; Zhu J; Mei L; Huang T; Qu X
    Front Endocrinol (Lausanne); 2022; 13():944758. PubMed ID: 35992148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and the risk of papillary thyroid cancer: a pooled analysis of three case-control studies.
    Xu L; Port M; Landi S; Gemignani F; Cipollini M; Elisei R; Goudeva L; Müller JA; Nerlich K; Pellegrini G; Reiners C; Romei C; Schwab R; Abend M; Sturgis EM
    Thyroid; 2014 Jun; 24(6):966-74. PubMed ID: 24555500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Aggressive Clinicopathologic Features of Papillary Thyroid Carcinoma and Body Mass Index: A Systematic Review and Meta-Analysis.
    Economides A; Giannakou K; Mamais I; Economides PA; Papageorgis P
    Front Endocrinol (Lausanne); 2021; 12():692879. PubMed ID: 34276564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.